778575-09-0 Usage
Uses
Used in Organic Synthesis:
(R)-1-cyclobutylethanaMine is used as a building block in the field of organic synthesis for the preparation of other important chemical compounds. Its unique structure and properties contribute to the development of novel molecules with potential applications in various industries.
Used in Research and Development:
(R)-1-cyclobutylethanaMine is used as a valuable tool in research and development, particularly for studying the structure and reactivity of organic molecules. Its specific orientation in space and unique properties make it an attractive subject for scientists working on the advancement of organic chemistry and related fields.
Used in Pharmaceutical Development:
(R)-1-cyclobutylethanaMine is used as a potential candidate in the development of new pharmaceuticals. Its unique structure and properties can be harnessed to create novel drugs with improved efficacy and selectivity, contributing to the advancement of medical treatments.
Used in Material Science:
(R)-1-cyclobutylethanaMine is used in the field of material science for the development of new materials. Its unique properties can be utilized to create innovative materials with enhanced performance characteristics, such as improved strength, durability, or chemical resistance.
Check Digit Verification of cas no
The CAS Registry Mumber 778575-09-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,8,5,7 and 5 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 778575-09:
(8*7)+(7*7)+(6*8)+(5*5)+(4*7)+(3*5)+(2*0)+(1*9)=230
230 % 10 = 0
So 778575-09-0 is a valid CAS Registry Number.
778575-09-0Relevant academic research and scientific papers
Ruthenium Catalyzed Direct Asymmetric Reductive Amination of Simple Aliphatic Ketones Using Ammonium Iodide and Hydrogen
Ernst, Martin,Ghosh, Tamal,Hashmi, A. Stephen K.,Schaub, Thomas
supporting information, (2020/07/14)
The direct conversion of ketones into chiral primary amines is a key transformation in chemistry. Here, we present a ruthenium catalyzed asymmetric reductive amination (ARA) of purely aliphatic ketones with good yields and moderate enantioselectivity: up to 99 percent yield and 74 percent ee. The strategy involves [Ru(PPh3)3H(CO)Cl] in combination with the ligand (S,S)-f-binaphane as the catalyst, NH4I as the amine source and H2 as the reductant. This is a straightforward and user-friendly process to access industrially relevant chiral aliphatic primary amines. Although the enantioselectivity with this approach is only moderate, to the extent of our knowledge, the maximum ee of 74 percent achieved with this system is the highest reported till now apart from enzyme catalysis for the direct transformation of ketones into chiral aliphatic primary amines.
SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE
-
Page/Page column 534, (2016/04/10)
Compounds having a structure of Formula (IX) or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b, R3a, R3b, R4a, R4b, Q1----Q2, R6, R7, A, B, W, x, and y are as defined herein and are provided. Pharmaceutical compositions comprising such compounds and methods for treating various HAT-related conditions or diseases, including cancer, by administration of such compounds are also provided.
